Blood biomarkers in cardioembolic stroke
Related Experiment Video
Updated: May 30, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Teresa García-Berrocoso1, Israel Fernández-Cadenas, Pilar Delgado
1Neurovascular Research Laboratory, Institut de Recerca Vall d'Hebron and Neurovascular Unit Neurology Department. Universitat Autònoma de Barcelona. Medicine Department. Hospital Vall d'Hebron. Barcelona, Spain.
Insights
Biomarkers like BNP, D-dimer, PITX2, and ZFHX3 show promise for diagnosing cardioembolic stroke. These tools could improve secondary prevention strategies for neurovascular diseases.
Area of Science:
- Neuroscience
- Cardiology
- Genetics
Background:
- Neurovascular diseases, particularly stroke, require accurate etiological diagnosis for effective treatment.
- Undetermined stroke etiology is common, complicating secondary prevention efforts.
- Biomarkers offer a potential avenue for improving diagnostic accuracy and patient management.
Purpose of the Study:
- To review current knowledge on biomarkers for cardioembolic stroke etiology.
- To highlight the potential of specific biomarkers in guiding diagnostic tests and secondary prevention.
Main Methods:
- Literature review of existing studies on stroke biomarkers.
- Focus on proteins (BNP, D-dimer) and genes (PITX2, ZFHX3) associated with cardioembolic stroke.
Main Results:
- BNP and D-dimer proteins are associated with cardioembolic events.
- PITX2 and ZFHX3 genes are implicated in cardioembolic stroke etiology.
- These biomarkers may aid in classifying stroke subtypes.
Conclusions:
- Biomarkers are crucial for advancing the diagnosis and classification of stroke etiology.
- Future application of these biomarkers could expedite secondary prevention strategies.
- Personalized medicine approaches in neurovascular diseases can be enhanced by biomarker utilization.
Abstract:
One promising field in neurovascular diseases investigation is the use of biomarkers to guide stroke etiology diagnosis and classification. Since treatment differs among etiologic subtypes and nowadays many patients receive a diagnosis of undetermined stroke, biomarkers might become an important additional diagnostic tool. In this review we update current knowledge about biomarkers related with cardioembolic stroke etiology (such as BNP and D-dimer proteins, or PITX2 and ZFHX3 genes), that in the future, might allow rapidly guiding other diagnostic tests and accelerating the onset of an optimal secondary prevention.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
05:30Isolation, Characterization, and Proteomic Analysis of Plasma-Derived Extracellular Vesicles for Cardiovascular Biomarker Discovery
Published on: January 31, 2025
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Hemorrhagic Stroke ll: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
Hemorrhagic Stroke l: Introduction
Ischemic Stroke l: Introduction